Meds Apotek AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	4.65	-2.41	-8.16	-49.12	-106.57
Depreciation & Amortization	-	20.18	20.75	20.64	-
Stock-Based Compensation	-	-	-0.59	-0.12	-
Other Adjustments	18.74	19.84	17.3	17.8	14.77
Change in Receivables	-1.58	-7.19	-13.98	1.27	-2.12
Changes in Inventories	-21.95	-41.9	-20.51	-15.12	-5.23
Changes in Accounts Payable	13.29	9.77	45.59	-4.52	-2.55
Changes in Other Operating Activities	0.68	0.56	0.3	0.13	0
Operating Cash Flow	13.56	-21.23	20.29	-49.6	-101.69
Operating Cash Flow Growth	-29.82%	-	-	-	-
Capital Expenditures	-5.33	-0.6	-0.45	-0.18	-8.88
Purchases of Intangible Assets	-7.53	-7.01	-7.78	-8.5	-15.73
Purchases of Investments	-0.4	-0.37	-0.3	-0.13	0
Investing Cash Flow	-13.26	-7.98	-8.52	-8.81	-24.61
Long-Term Debt Issued	-	-	-	29.7	0
Long-Term Debt Repaid	-	-	-30	-	0
Net Long-Term Debt Issued (Repaid)	-	-	-30	29.7	0
Issuance of Common Stock	70	70	-	62.51	80.16
Net Common Stock Issued (Repurchased)	70	70	-	62.51	80.16
Other Financing Activities	-18.44	-16.79	-11.18	-7.95	-7.98
Financing Cash Flow	51.55	53.21	-41.18	84.26	72.19
Net Cash Flow	51.85	24	-29.42	25.85	-54.11
Free Cash Flow	8.23	-21.83	19.84	-49.78	-110.57
FCF Margin	0.75%	-2.14%	2.37%	-7.54%	-18.29%
Free Cash Flow Per Share	0.44	-1.22	1.15	-2.97	-7.21
Levered Free Cash Flow	1.66	-4.26	5.28	-20.37	-126.17
Unlevered Free Cash Flow	1.59	-5.79	38.05	-47.73	-124.98